Pennsylvania Convention Authority Renews ASM Global Management Contract Becoming First Venue in World Leader’s ‘Premier Package’ Convention Center Expansion
24.8.2023 23:46:00 EEST | Business Wire | Press release
The Pennsylvania Convention Center Authority (PCCA) board of directors has approved a five-year contract renewal for ASM Global as its venue management company with the convention center poised as the launch location for a dramatic series of innovations in ASM Global’s convention and conference portfolio — the largest in North America and worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230824372126/en/
Photo courtesy of ASM Global.
The new agreement will commence on Dec. 1, 2023, for five years, through Nov. 30, 2028, with the international entertainment leader planning to bring many of its most innovative designs to a leading group of convention centers beginning with PCCA. It will be the first in a program creating unique environments such as immersive LED moments, speed-action offerings to accelerate business strategies, elevated VIP lounges and quiet spaces for business connectivity.
“We are thrilled to announce the continued partnership between the Pennsylvania Convention Center Authority and ASM Global as the venue-management provider for the Pennsylvania Convention Center,” said David A. Nasatir, Esq., chair of the board, PCCA. “For 10 years, ASM Global has been a valued collaborator and, because of their outstanding contributions, has elevated the Pennsylvania Convention Center to world-class status.”
In 2013 the PCCA first made the decision to privatize management of the center with an initial contract being awarded to SMG, which was subsequently rebranded to ASM Global following the 2019 merger of AEG Facilities and SMG. The merger created a venue management powerhouse that spans five continents, 14 countries and more than 350 of the world’s most prestigious arenas, stadiums, theaters and convention centers and has positioned ASM Global as the world’s preeminent venue-management and live-experiences company.
“The ASM Global team at the Pennsylvania Convention Center is, without exception, the finest in the industry,” said John J. McNichol, president and CEO, PCCA. “Their innovative leadership and commitment to delivering an unmatched customer experience have positioned the center, globally, as an industry trailblazer and venue of choice, and we look forward to continuing our collaboration as we take the Pennsylvania Convention Center to the next level.”
Under the management of ASM Global, the Pennsylvania Convention Center has already implemented several cutting-edge and industry-changing initiatives such as the 2014 execution of the Customer Satisfaction Agreement, a document that guides the relationship between the center and the labor unions that work at the facility with the goal of providing a more productive, customer-centric and cost-effective worksite for guests and the ASM Global Acts program, under which the center has successfully executed a robust sustainability and social impact plan.
Dan Hoffend, ASM Global executive vice president, convention centers, said, “We’re excited to begin the next chapter for the convention universe beginning with the Pennsylvania Convention Center. This includes sustainability features that create substantial movement toward carbon neutral; new Flex-space exhibit halls that can adapt to the needs of our diverse attendees; and LED walls that provide sponsorship, wayfinding and entertainment.
“We’re bringing our proven best features from our stadiums and arenas directly to our convention centers to create a premium line of facilities like no other in the industry. Our attendees require entertainment as a part of their business paradigm. We are changing the industry by creating a unique environment for all of our guests,” Hoffend said.
PCC’s ASM Global general manager, Tony Hodgins, said, “We thank the PCCA for their continued trust in our ASM Global team and for their unwavering support over the years. Our team at the center remains focused on our goal of providing a first-class customer experience to all our guests, and we are honored to be able to continue working with our key partners to showcase all that Philadelphia and the Pennsylvania Convention Center have to offer.”
For more information on the Pennsylvania Convention Center community-engagement and outreach initiatives, visit paconvention.com.
About Pennsylvania Convention Center
Pennsylvania Convention Center is located in Center City Philadelphia at the heart of the city's many cultural offerings and world-class dining and entertainment scene. Managed by ASM Global, the center is the 14th largest facility in the nation and features one of the largest exhibit spaces and ballrooms in the Northeastern U.S. The meetings, conventions, trade shows and other events hosted by the center attract attendees from across the country and around the world to Philadelphia, making the facility the largest economic driver of the region’s hospitality industry. For more information, visit paconvention.com.
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and event strategy and management, delivering locally tailored solutions and cutting-edge technologies to achieve maximum results for venue owners. The company’s elite venue network spans five continents, with a portfolio of more than 350 of the world’s most prestigious arenas, stadiums, convention and exhibition centers, and performing arts venues. Follow us on Facebook, Instagram, LinkedIn and Twitter. For more information, please visit asmglobal.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230824372126/en/
Contact information
Jim Yeager
breakwhitelight (for ASM Global)
jim@breakwhitelight.com
818-264-6812
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
